These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8555464)

  • 1. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.
    Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y
    Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets.
    Miyakawa Y; Oda A; Druker BJ; Ozaki K; Handa M; Ohashi H; Ikeda Y
    Blood; 1997 Apr; 89(8):2789-98. PubMed ID: 9108397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
    Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
    EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro.
    Ezumi Y; Takayama H; Okuma M
    FEBS Lett; 1995 Oct; 374(1):48-52. PubMed ID: 7589510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel MPL point mutation resulting in thrombopoietin-independent activation.
    Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
    Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
    Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
    FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin induces association of Crkl with STAT5 but not STAT3 in human platelets.
    Ozaki K; Oda A; Wakao H; Rhodes J; Druker BJ; Ishida A; Wakui M; Okamoto S; Morita K; Handa M; Komatsu N; Ohashi H; Miyajima A; Ikeda Y
    Blood; 1998 Dec; 92(12):4652-62. PubMed ID: 9845531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
    Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
    Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p120c-cbl is present in human blood platelets and is differentially involved in signaling by thrombopoietin and thrombin.
    Oda A; Ozaki K; Druker BJ; Miyakawa Y; Miyazaki H; Handa M; Morita H; Ohashi H; Ikeda Y
    Blood; 1996 Aug; 88(4):1330-8. PubMed ID: 8695851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction by the peptide which mimics the activity of thrombopoietin.
    Kimura T; Kaburaki H; Tsujino T; Watanabe Y; Kato H
    Biochem Mol Biol Int; 1998 May; 44(6):1203-9. PubMed ID: 9623775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets.
    Schulze H; Ballmaier M; Welte K; Germeshausen M
    Exp Hematol; 2000 Mar; 28(3):294-304. PubMed ID: 10720694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
    Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.
    Oda A; Miyakawa Y; Druker BJ; Ishida A; Ozaki K; Ohashi H; Wakui M; Handa M; Watanabe K; Okamoto S; Ikeda Y
    Blood; 1996 Dec; 88(11):4304-13. PubMed ID: 8943867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism.
    Brizzi MF; Battaglia E; Montrucchio G; Dentelli P; Del Sorbo L; Garbarino G; Pegoraro L; Camussi G
    Circ Res; 1999 Apr; 84(7):785-96. PubMed ID: 10205146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
    Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
    Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.